
Watch the full episode below:
Listen to the full episode on Spotify:
In the penultimate ‘solli sessions’ of 2024, Jo Halliday, CEO of Talking Medicines, joins solli CEO Richard Springham to discuss the journey of Talking Medicines – a data and AI company looking to shape the future of pharma marketing.
Together, they delve into the company’s heritage in data and AI, the impact of ChatGPT’s launch on the industry, and its ambitions for the future of pharma media.
In this exclusive interview, Jo and Richard explore:
To dive into all solli Sessions podcast episodes click HERE.
Create your FREE account to continue reading and explore more expert insights on Pharma Media.
✅ Free. Fast. No commitment.